BCKDK and Parkinson disease: Disruptions in BCAA homeostasis—arising from gut microbiota dysbiosis and dysregulated expression of key metabolic enzymes such as BCKDK—have been increasingly linked to the pathogenesis of Parkinson’s disease (PD).